CONTACT
+91 80 2808 2808
info@biocon.com

Biocon Limited receives the final inspection report from EDQM

  • Posted by: BIOCON
NOTIFICATION TO STOCK EXCHANGE

COMPANY STATEMENT

Bengaluru, Karnataka, India, Dec 22, 2022

“This is to inform you that Biocon Limited has been issued a Good Manufacturing Practice (GMP) Certificate of Compliance by the European Directorate for the Quality of Medicines & HealthCare (EDQM), for our Active Pharmaceutical Ingredient (API) manufacturing facility in Bangalore. This certification is based on a GMP inspection of the site that was conducted between the 12th and 14th of September 2022.”

 

Author: BIOCON
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>